Bone densitometry manufacturer Lunar of Madison, WI, fell into the red for its third quarter of fiscal 1999 (end-March), despite posting an increase in revenues. The company said that lower profit margins from an increase in dealer sales, a $1 million
Bone densitometry manufacturer Lunar of Madison, WI, fell into the red for its third quarter of fiscal 1999 (end-March), despite posting an increase in revenues. The company said that lower profit margins from an increase in dealer sales, a $1 million charge for doubtful accounts in financially troubled Brazil, and higher sales and marketing expenses conspired to produce the loss.
For the quarter, Lunar recorded sales of $19.7 million, up 10% compared with $18 million in the same period a year ago. The companys third-quarter net loss was $825,000, compared with net income of $692,000 in the third quarter of 1998. Lunar received $2.7 million in orders for its new E-Scan extremity MRI scanner during the quarter, but was not able to recognize revenue from the systems, due to shipping delays at E-Scans manufacturer, Esaote of Genoa, Italy.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.